-
公开(公告)号：US20200376198A1
公开(公告)日：2020-12-03
申请号：US16995004
申请日：2020-08-17
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
Abstract: A biosensor includes an optical circuit that obtains a plurality of photoplethysmography (PPG) signals from light at different wavelengths that is reflected from or transmitted through tissue of a user. A processing circuit determines a measurement value for a nitric oxide (NO) level in blood flow using first and second PPG signals and determines an insulin response from caloric intake using the measurement value for the NO level in blood flow. The first PPG signal is obtained from light at a wavelength having a high absorption coefficient for NO in blood flow and the second PPG signal is obtained from light at a second wavelength having a low absorption coefficient for NO in blood flow. The processing circuit also determines one or more phases of digestion using at least one or more of the plurality of PPG signals.
-
公开(公告)号：US10744261B2
公开(公告)日：2020-08-18
申请号：US16172661
申请日：2018-10-26
Applicant: SANMINA CORPORATION
Inventor： Robert Steven Newberry , Matthew Rodencal
IPC: A61B5/00 , A61B5/1455 , A61B5/024 , A61B5/0295 , A61M5/172 , A61M5/142 , A61M5/32 , A61B5/02 , A61M5/145 , A61B5/01 , A61B5/08 , A61B5/021
Abstract: An optical circuit detects PPG signals reflected from skin tissue at one or more different wavelengths. A processing circuit integrated in the biosensor or in communication with the biosensor processes the PPG signals to obtain a level of vasodilation or a period of vasodilation. The processing circuit may determine a circulation level using a phase offset between the PPG signals and/or a correlation value between the PPG signals.
-
公开(公告)号：US20210259640A1
公开(公告)日：2021-08-26
申请号：US17199337
申请日：2021-03-11
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
Abstract: A photoplethysmography (PPG) circuit obtains PPG signals at a plurality of wavelengths of light reflected from tissue of a user. A processing device generates parameters using the PPG signals to determine a glucose level in blood flow of the user. The parameters include one or more ratio values obtained using the plurality of PPG signals; a phase delay between the plurality of PPG signals; a correlation of phase shape between the plurality of PPG signals or a periodicity of one or more of the plurality of PPG signals.
-
公开(公告)号：US20200253562A1
公开(公告)日：2020-08-13
申请号：US16848646
申请日：2020-04-14
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
Abstract: A photoplethysmography (PPG) circuit obtains PPG signals at a plurality of wavelengths of light reflected from tissue of a user. A processing device generates parameters using the PPG signals to screen the user for an infection, such as sepsis, influenza and/or COVID-19. The processing device may also determine a severity level of the infection and a confidence level in the determination. The parameters may include a measurement of nitric oxide (NO) level, respiration rate, heart rate and/or oxygen saturation.
-
公开(公告)号：US10672298B2
公开(公告)日：2020-06-02
申请号：US15707914
申请日：2017-09-18
Applicant: Sanmina Corporation
Inventor： Robert Newberry , Matthew Rodencal , Nate Roth
IPC: G09B23/30 , F03B13/14 , A61B5/02 , A61B5/145 , A61B5/1495
Abstract: A blood flow simulator generates a compression and expansion in a test fluid that emulates the pressure waveform created by a heartbeat in blood flow. The blood flow simulator stores a plurality of pressure waveform files that include actual data recorded from a heartbeat, arterial pressure waveform, or venous pressure waveform. One or more of the pressure waveform files may be selected and the pressure waveform file is used by the blood flow simulator 100 to generate a pressure waveform in pressurized fluid. The pressurized fluid flows through a test site, such as a surrogate body part or an optical window or other component with material having similar properties to human tissue. Various target substances may also be added to the fluid in known concentrations for testing and configuration of medical devices at the test site.
-
Patent Agency Ranking
公开(公告)号：US20200368432A1
公开(公告)日：2020-11-26
申请号：US16993944
申请日：2020-08-14
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
IPC: A61M5/172 , A61B5/0295 , A61B5/024 , A61B5/1455 , A61M5/142 , A61M5/32 , A61B5/02
Abstract: An optical circuit detects PPG signals reflected from skin tissue at one or more different wavelengths. A processing circuit integrated in the biosensor or in communication with the biosensor processes the PPG signals to obtain a period of vasodilation, a level of vasodilation and rate of change of the level of vasodilation. The processing circuit compares the level of vasodilation to a normal range and determines an arterial stiffness index using the comparison and the rate of change of the level of vasodilation.
-
公开(公告)号：US20190060568A1
公开(公告)日：2019-02-28
申请号：US16172661
申请日：2018-10-26
Applicant: SANMINA CORPORATION
Inventor： Robert Steven Newberry , Matthew Rodencal
Abstract: An optical circuit detects PPG signals reflected from skin tissue at one or more different wavelengths. A processing circuit integrated in the biosensor or in communication with the biosensor processes the PPG signals to obtain a level of vasodilation or a period of vasodilation. The processing circuit may determine a circulation level using a phase offset between the PPG signals and/or a correlation value between the PPG signals.
-
公开(公告)号：US20170014572A1
公开(公告)日：2017-01-19
申请号：US15276760
申请日：2016-09-26
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
CPC classification number: A61M5/1723 , A61M5/14248 , A61M5/145 , A61M5/3298 , A61M2205/3306 , A61M2205/3584 , A61M2205/502 , A61M2205/52 , A61M2205/8206 , A61M2205/8268 , A61M2230/06 , A61M2230/20 , A61M2230/30 , A61M2230/42 , A61M2230/50 , A61M2230/63
Abstract: An integrated drug delivery and biosensor (IDDB) system is implemented on a patch or arm band. The drug delivery system includes needles adapted to pierce the skin and direct injection of a predetermined dosage of medication through the needles into the epidermis of the skin of a patient. The integrated biosensor monitors absorption of the medication into the epidermis of the skin of the patient and may also monitor concentration of the medication or other relevant substances in arterial blood flow of the patient. The integrated biosensor may also monitor a patient's vitals in response to the medication. The integrated biosensor may then alter dosage or frequency of administration of dosages or even halt a dosage of medication in response to the patient's vitals or absorption of the medication.
Abstract translation: 在贴片或手臂带上实施综合药物递送和生物传感器（IDDB）系统。 药物递送系统包括适于刺穿皮肤并且将预定剂量的药物通过针直接注射到患者皮肤的表皮中的针。 集成的生物传感器监测药物对患者皮肤的表皮的吸收，还可以监测患者动脉血流中药物或其他相关物质的浓度。 集成的生物传感器还可以响应于药物监测患者的生命体征。 然后，集成的生物传感器可以改变施用剂量的剂量或频率，或者甚至响应于患者的生命体征或药物的吸收而停止一定剂量的药物。
-
公开(公告)号：US10744262B2
公开(公告)日：2020-08-18
申请号：US16183354
申请日：2018-11-07
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
Abstract: A biosensor is implemented in an earpiece and includes an activity monitoring circuit that detects an activity level of a user and an optical circuit that detects a plurality of spectral responses at a plurality of wavelengths from light reflected from skin of the user. The biosensor determines a heart rate and an oxygen saturation level using the plurality of spectral responses and determines whether the heart rate or the oxygen saturation level reaches a predetermined threshold for the activity level of the user. The biosensor generates an alert and transmits the alert wirelessly to a remote device.
-
公开(公告)号：US10155087B2
公开(公告)日：2018-12-18
申请号：US15485816
申请日：2017-04-12
Applicant: Sanmina Corporation
Inventor： Robert Steven Newberry , Matthew Rodencal
Abstract: A biosensor detects a medication applied to an upper epidermal layer of skin of a user. The biosensor obtains at periodic intervals a concentration level of the medication in the upper epidermal layer of skin and surrounding tissue of the user. The biosensor may also detect the concentration level of the medication in an arterial blood flow of the patient or obtain a concentration level of a substance in the arterial blood flow, wherein the concentration level of the substance correlates to a first concentration level of the medication. The biosensor may determine an absorption rate of the medication in the upper epidermal layer of skin and surrounding tissue and in an arterial blood flow of the patient from the detected concentration levels of the medication obtained at the periodic intervals.
-
-
-
-
-
-
-
-
-
Search Results
18
records
(took 0.013 seconds)
